Pain News and Research

Latest Pain News and Research

Amgen announces romosozumab Phase 2 trial results in postmenopausal women with low BMD

Amgen announces romosozumab Phase 2 trial results in postmenopausal women with low BMD

Researchers reveal how emotions are experienced in body

Researchers reveal how emotions are experienced in body

Study examines prevalence, severity and factors associated with chronic pain after breast cancer surgery

Study examines prevalence, severity and factors associated with chronic pain after breast cancer surgery

Melatonin plays major role in pain transmission

Melatonin plays major role in pain transmission

Blood pressure monitors, pain relief products and first-aid products are FSA eligible expenses

Blood pressure monitors, pain relief products and first-aid products are FSA eligible expenses

Elementary school administrator donates healthy kidney to total stranger

Elementary school administrator donates healthy kidney to total stranger

Ancient Peru healers drilled holes in the cranium for treatment

Ancient Peru healers drilled holes in the cranium for treatment

Surgery leads to greater long-term improvement for patients with herniated discs in lower spine

Surgery leads to greater long-term improvement for patients with herniated discs in lower spine

FIDELITY project compares surgical treatment of degenerative meniscal tears to placebo surgery

FIDELITY project compares surgical treatment of degenerative meniscal tears to placebo surgery

Researchers catalogue compassionate words and actions in doctor-patient conversations

Researchers catalogue compassionate words and actions in doctor-patient conversations

Older adults with low back pain are interested in receiving co-managed care, shows study

Older adults with low back pain are interested in receiving co-managed care, shows study

EMA accepts Otsuka's marketing authorisation application for tolvaptan for treatment of ADPKD

EMA accepts Otsuka's marketing authorisation application for tolvaptan for treatment of ADPKD

State highlights: Mass. compounding pharmacy agrees to $100M victim settlement over meningitis outbreak; Texas grand jury clears late-term abortion provider

State highlights: Mass. compounding pharmacy agrees to $100M victim settlement over meningitis outbreak; Texas grand jury clears late-term abortion provider

Combination of medication and psychological therapy effective for treating chronic migraines in children

Combination of medication and psychological therapy effective for treating chronic migraines in children

Cognitive behavioral therapy reduces headache frequency, migraine-related disability in children

Cognitive behavioral therapy reduces headache frequency, migraine-related disability in children

Antidepressant nortriptyline does not improve overall symptoms in patients with idiopathic gastroparesis

Antidepressant nortriptyline does not improve overall symptoms in patients with idiopathic gastroparesis

Diflunisal drug reduces neurological decline in patients with familial transthyretin amyloidosis

Diflunisal drug reduces neurological decline in patients with familial transthyretin amyloidosis

FDA extends PDUFA Priority Review action date for UC indication of Takeda's vedolizumab

FDA extends PDUFA Priority Review action date for UC indication of Takeda's vedolizumab

Young women more likely to have negative urodynamics experience

Young women more likely to have negative urodynamics experience

First Edition: December 24, 2013

First Edition: December 24, 2013

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.